Quest Diagnostics held a conference call to discuss its financial results for the second quarter of 2008. The call began with introductory remarks noting some statements may be forward-looking and cautioning investors. Surya Mohapatra then stated the business performed well, with double digit revenue and earnings growth. Revenue was $1.8 billion, up 12%, and earnings per share increased 14%. Cash flow also improved. Bob Hagemann then reviewed the financial results in more detail, noting continued revenue, volume, and earnings growth. He also provided an update on cost reduction initiatives and guidance for the full year.